Maxcort 30 Tablet

About Maxcort 30 Tablet

Made by Novatek Pharmaceuticals Ltd., Maxcort 30 is a tablet whose active ingredient is Deflazacort. Maxcort 30 is used in conditions where reducing inflammation or suppressing the immune system helps.

There are 28 brands of Deflazacort listed in Bangladesh. The lowest listed price is Dezert 6 mg Tablet at ৳ 8.00 per unit.

What is Maxcort 30 Tablet?

Made by Novatek Pharmaceuticals Ltd., Maxcort 30 is a tablet whose active ingredient is Deflazacort. It works by reducing inflammation and suppressing certain immune system activities. It is prescribed for conditions such as severe allergic reactions, asthma, rheumatoid arthritis and other inflammatory or immune-related disorders. Use it only as your doctor directs.

Uses of Maxcort 30

Maxcort 30 is used in conditions where reducing inflammation or suppressing the immune system helps. Maxcort 30 is used in adults for a range of inflammatory and immune-related conditions. It may also be used in other conditions where a corticosteroid is needed. Your doctor will decide if this medicine is appropriate for your specific condition.

How to use Maxcort 30

Do not take extra tablets to make up for a missed dose. Maxcort 30 is taken by mouth. Swallow the tablet with water. Take Maxcort 30 30 mg tablet exactly as the doctor tells you. Do not change the dose or stop taking the tablet without medical advice. The dose and how often you take it depend on your condition and will be set by your doctor.

Side effects of Maxcort 30

Some people become more prone to infection, heal more slowly, or notice skin changes such as thinning, stretch marks or acne. Like all medicines, Maxcort 30 30 mg tablet can cause side effects. Call the doctor if you see signs of infection, severe stomach pain, unusual weight gain, swelling, or changes in vision. Tell your doctor if you notice any unusual symptoms.

Safety and precautions

Do not start or stop this medicine without your doctor's guidance. If you are pregnant or breastfeeding, talk to your doctor first, as corticosteroids may affect the baby. This medicine may not be suitable for people with certain infections or those receiving live vaccines. Ask your doctor first if any of these apply to you.

Frequently asked questions

Why is Maxcort 30 prescribed?

Maxcort 30 is used in conditions where reducing inflammation or suppressing the immune system helps. Maxcort 30 is used in adults for a range of inflammatory and immune-related conditions.

How do I use Maxcort 30 correctly?

Do not take extra tablets to make up for a missed dose. Maxcort 30 is taken by mouth.

What should I watch for while using Maxcort 30?

Some people become more prone to infection, heal more slowly, or notice skin changes such as thinning, stretch marks or acne. Like all medicines, Maxcort 30 30 mg tablet can cause side effects.

Can I use Maxcort 30 in pregnancy or while breastfeeding?

Do not start or stop this medicine without your doctor's guidance. If you are pregnant or breastfeeding, talk to your doctor first, as corticosteroids may affect the baby.

Indications

Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • ... Read more
Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • Pemphigus,bullous pemphigoid, pyoderma gangrenosum
  • Minimal change nephrotic syndrome, acute interstitial nephritis
  • Rheumatic carditis
  • Ulcerative colitis, Crohn's disease
  • Uveitis, optic neuritis
  • Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura
  • Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma
  • Immune suppression in transplantation

Pharmacology

Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals Deflazacort provides immunosuppressive action.

Dosage & Administration

Adults-
  • For acute disorders: Up to 120 mg/day Deflazacort may need to be given initially. Maintenance doses in most conditions are within the range of 3-18 mg/day.
  • Rheumatoid arthritis: The maintenance dose is usually within the range of 3-18 mg/day. The smallest effective dose should be used and increased if necessary.
  • Bronchial asthma: In the treatment of an acute attack, high doses of 48-72 mg/day may be needed depending on severity and gradually reduced once the attack has been controlled. For maintenance in chronic asthma, doses should be titrated to the lowest dose that controls symptoms.
  • Other conditions: The dose of Deflazacort depends on clinical need titrated to the lowest effective dose for maintenance. Starting doses may be estimated on the basis of ratio of 5 mg prednisone or prednisolone to 6 mg.
Children: There has been limited exposure of children to Deflazacort in clinical trials. In children, the indications for glucocorticoids arethe same as for adults, but it is important that the lowest effective dosage is used. Alternate day administration may be appropriate. Doses of Deflazacort usually lie in the range 0.25-1.5 mg/kg/day.

The following ranges provide general guidance:
  • Juvenile chronic arthritis: The usual maintenance dose is between 0.25-1.0 mg/kg/day.
  • Nephrotic syndrome: Initial dose of usually 1.5 mg/kg/day followed by down titration according to clinical need.
  • Bronchial asthma: On the basis of the potency ratio, the initial dose should be between 0.25-1.0 mg/kg on alternate days.
Deflazacort withdrawal: In patients who have received more than physiological doses of systemic corticosteroids (approximately 9 mg per day or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced.

Interaction

Deflazacort is metabolized in the liver. It is recommended to increase the maintenance dose of Deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, (e.g. ketoconazole) it may be possible to reduce the maintenance dose of Deflazacort.

Contraindications

Hypersensitivity to or any of the ingredients. Patients receiving live virus immunization.

Side Effects

GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent Ml, thromboembolism.

Pregnancy & Lactation

Pregnancy: Deflazacort does cross the placenta. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intrauterine growth retardation. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.

Nursing Mother: Corticosteroids are excreted in breast milk, although no data are available for Deflazacort. Doses of up to 50 mg daily of Deflazacort are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breastfeeding are likely to outweigh any theoretical risk.

Precautions & Warnings

The following clinical conditions require special caution and frequent patient monitoring is necessary-
  • Cardiac disease or congestive heart failure (except in the presence of active rheumatic carditis), hypertension, thromboembolic disorders. Glucocorticoids can cause salt and water retention and increased excretion of potassium. Dietary salt restriction and potassium supplementation may be necessary.
  • Gastritis or oesophagitis, diverticulitis, ulcerative colitis if there is the probability of impending perforation, abscess or pyogenic infections, fresh intestinal anastomosis, active or latent peptic ulcer.
  • Diabetes mellitus or family history, osteoporosis, myasthenia gravis, renal insufficiency.
  • Emotional instability or psychotic tendency, epilepsy.
  • Previous corticosteroid-induced myopathy.
  • Liver failure.
  • Hypothyroidism and cirrhosis, which may increase the glucocorticoid effect.
  • Ocular herpes simplex because of possible corneal perforation.

Storage Conditions

Store in a cool (below 25°C) and dry place, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Deflazacort

Other brands with the same generic name, cheapest first.

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.